Ameet Mallik - 09 Aug 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ David Tucker, Attorney-in-Fact for Ameet Mallik
Issuer symbol
ATRA
Transactions as of
09 Aug 2021
Net transactions value
$0
Form type
4
Filing time
10 Aug 2021, 16:59:12 UTC
Previous filing
28 May 2021
Next filing
12 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRA Non-Qualified Stock Option (Right to Buy) Award $0 +55,000 $0.000000 55,000 09 Aug 2021 Common Stock 55,000 $12.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as to 1/3rd of the shares on the first, second and third anniversaries of August 9, 2021, subject to the Reporting Person's continuous service.